Wondering if Astellas Pharma is still worth buying after its big run, or if the easy money has already been made? In this article, we walk through what the market is pricing in and where the gaps ...

For those willing to take a chance, let's consider two biotech stocks that could eventually become solid, well-established drugmakers: CRISPR Therapeutics ( CRSP 0.76%) and Viking Therapeutics ( VKTX ...

Wondering if Nuvation Bio at around 8.66 is still a smart buy after its big run, or if most of the upside is already priced in? This article is designed to unpack that value question in plain English.

Background In December 2022, California prohibited the sale of most flavoured tobacco products; however, limited data are ...

Families, sheriffs and providers agree: jail is often the default response to addiction, even as withdrawal can become a ...